This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Manipulation of the Gut Microbiota for Metabolic Health
joint with Microbiome, Host Resistance and Disease
Organizer(s): Nathalie Delzenne and Liping Zhao
Date: March 04 - 08, 2018
Location: Fairmont Banff Springs, Banff, AB, Canada
Sponsored by Merck & Co., Inc. and Takeda Pharmaceutical Company Limited
Summary of Meeting:
The main objective of this Keystone Symposia conference is to evaluate the contribution of the gut microbiota to diseases characterized by alterations of host energy metabolism, and to highlight development of new therapeutic and nutritional approaches. Innovative models allow us to better elaborate the link between gut microbiota, the environment (including nutrition and xenobiotics – drugs, contaminants, additives) and host physiology, namely by focusing on specific metabolites produced by the gut microbes. As compared to previous meetings organized in the same field, additional metabolic disorders will be covered, including undernutrition and cachexia, disturbances of gut-muscle axis and cardiovascular dysfunction. Special attention will be brought to innovative tools to manipulate the gut microbiota, implicating both academic and industry research. The symposium will bring together a multidisciplinary audience to explore the vast amount of existing data (metagenomics and metabolomics dataset) that can be leveraged to elaborate novel tools to modulate the gut microbiota for host health.
Scholarship Deadline: November 1 2017
Discounted Abstract Deadline: November 1 2017
Abstract Deadline: December 1 2017
Discounted Registration Deadline: January 9 2018
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Merck & Co., Inc.Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional support from these exhibitors at this conference:
Anaerobe Systems
We gratefully acknowledge additional support for this conference from:
eLifeMercodia, Inc.Research Diets, Inc.Seres TherapeuticsZymo Research Corporation
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK116615-01
Funding for this conference was made possible (in part) by 1 R13 DK116615-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found